retatrutide phase 2 trial obesity nejm 2023 VisualAbstract: reduces body weight by 17.5% in patients with retatrutide phase 2 trial obesity

Specification and emulation of the reference trial including our expansion studies are stated in the Supplementary Information, following the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guideline (Supplementary Tables 2729) 42

For anyone following retatrutide or taking part in a trial, that means one place for a shot log, body diagram site tracking, side effect notes, food logging, the medication graph, and the long weight trend

These types of fat are linked to metabolic health, which is why weight loss is not only about looking slimmer

Researchers interested in supporting skin health during rapid weight loss may want to explore peptides for anti-aging and collagen-supporting interventions that promote elastin and collagen synthesis

In Alzheimers disease, brain IR reduces amyloid- (A) clearance and promotes neurodegeneration

It is provided solely for laboratory research purposes and must not be used for diagnostic or therapeutic purposes, in food, cosmetics, or any medical applications